27 June 2021 in Grekov's Bulletin of Surgery
We carried out the systematic review of the domestic and foreign literature focusing on surgical treatment of patients with thymic pathology. Special attention was paid to the discussion of the advantages of minimally invasive surgery, particularly, video endoscopic thymectomy from subxiphoid access. Pubmed, Medline and E-library databases were searched for retrospective and prospective randomized trials. Based on the analysis of literature sources, we presented the data on tumor and non-tumor pathology of the thymus gland, clarified indications for surgical treatment in different types of thymic pathology. Variants of thymectomy were described, a brief historical review of the use of the surgical method in patients with thymus gland pathology was conducted. The technique of surgeries, advantages and weak points of various surgical approaches were described. We focused our attention on minimally invasive interventions, listed its advantages in comparison with the standard “open” surgical approach. The contemporary trends in surgical approaches in thymus pathology were discussed. Minimally invasive thymectomy is modern, safe and feasible variant of surgical treatment of patients with tumor and non-tumor pathology of the thymus gland. The subxiphoid approach allows to reduce postoperative pain, provides an excellent view of mediastinal structures and both pleural cavities, which improves the safety of operation with satisfactory cosmetic results.
1 January 2022 in P.A. Herzen Journal of Oncology
4 August 2025 in Siberian journal of oncology
Thymoma is a tumor originating from the epithelial cells of the thymus. In cases when complete removal of the tumor is not possible due to its local spread, induction therapy, including chemotherapy, radiotherapy, or chemoradiotherapy, is administered to improve respectability.Case presentation. We present a case of a 41-year-old male who was diagnosed with IVA type B3 thymoma (cT3N0M1a) in March 2022. Computed tomography (18.02.22) revealed a tumor in the anterior mediastinum measuring 12.0×8.0×14.5 cm with spread to the right lung and pericardium, compression of large vessels; single nodular lesions along the pleura. From 19.03.22 to 26.05.22, 4 cycles of polychemotherapy with CAP were administered. From 9.08.22 to 24.11.22, 6 cycles of chemotherapy with etoposide + cisplatin were administered. Stable disease was observed. In January, 2023, the patient visited A. Tsyb MRRC for a consultation with oncologists. Surgery was not considered as a suitable treatment option due to the spread of the disease, and radiation therapy was recommended. From 16.02.23 to 3.04.23, a conformal external beam radiation therapy was delivered to a mediastinal tumor to a total dose of 60 Gy. The treatment was well tolerated. A control examination showed tumor size reduction meaning the tumor can be surgically removed. Considering positive response to radiation therapy, satisfactory performance status and age of the patient, a decision to perform surgery was made. On September 15, 2023 the mediastinal tumor was removed with pericardial resection and its reconstruction, upper and middle lobectomy, and precision removal of parietal pleural lesions. A follow-up examination (October 2024) revealed disease progression with the appearance of nodular lesions along the diaphragmatic pleura on the right. Chemotherapy with pemetrexed was administered. Currently, the performance status of the patient is satisfactory and he is socially active.Conclusion. Induction chemotherapy and radiotherapy for locally advanced unresectable thymoma can increase the feasibility of achieving complete tumor resection, thus improving treatment outcomes. The rarity of these tumors and the lack of standard approaches to the treatment of locally advanced thymic carcinomas determine the relevance of the problem and the need to make an optimal decision on treatment tactics in each specific clinical case.
20 March 2026 in Research and Practical Medicine Journal
To date, surgical treatment remains the main therapeutic option for patients with chest wall tumors. Given the importance of preserving the structural integrity of the thoracic cage during extensive resections, the choice of reconstruction method for post-resection chest wall defects remains one of the key challenges in thoracic surgery.This clinical case report presents the treatment outcomes of a 64‑year-old female patient diagnosed with primary multiple metachronous malignancies who underwent rib resection followed by alloplastic reconstruction using a patient-specific 3D implant made of a nickel–titanium alloy. The implant was designed based on an individualized model and featured a double-locking mechanism using clamp-type fixation. At the 12‑month follow-up, no evidence of tumor recurrence was detected; the implant remained stable, the physiological volume of the thoracic cavity was preserved, and no signs of paradoxical respiration were observed. The proposed patient-specific modular 3D implant is convenient for intraoperative placement, allowing minimization of the risk of bleeding and infectious complications, as well as reduction of operative time. The technique of sternal and rib reconstruction using a patient-specific modular 3D implant is safe and effective and can be widely implemented in clinical practice.
14 May 2026 in P.A. Herzen Journal of Oncology
One of the challenges in thoracic surgery is the development of chronic pain syndrome following thoracoscopic procedures due to intercostal nerve injury. The use of spaces beneath the costal arch and subxiphoidally for placing “large” thoracoports is presented as an alternative approach to avoid this complication. Objective. To evaluate the immediate outcomes of thoracoscopic anatomical lung resections for malignant neoplasms performed via a subxiphoid approach. Material and Methods. The subxiphoid approach group included six patients, with a mean age of 67±5 years. Four surgical procedures in the form of lobectomy were performed for primary peripheral non-small cell lung cancer at stages IA3 and IB. Two segmentectomy procedures were conducted for solitary secondary lesions. The comparison group consisted of six patients aged 61±5 years, operated on using a multiport intercostal thoracoscopic technique for primary malignant lung tumors in the form of lobectomy. Results. The operative time in the subxiphoid approach group was 235±13 minutes, compared to 170±15 minutes in the comparison group. Blood loss volume was 125±15 ml and 75±15 ml, respectively. The postoperative period was uneventful in both groups. The mean hospital stay was 6.5±1.5 days in the subxiphoid group and 7.5±1.5 days in the comparison group. Pain intensity measured on the Visual Analogue Scale, (VAS) in the subxiphoid group was: day 1 — 3.5 points, day 3 — 2.5 points, discharge day — 1.5 points. In comparison, the intercostal multiport thoracoscopy group scored: day 1 — 4.5 points, day 3 — 3.5 points, discharge day — 2.5 points. Conclusion. The subxiphoid approach can be used for anatomical lung resection without compromising efficacy or safety. Performing thoracoscopic anatomical lung resections using a subxiphoid approach results in reduced postoperative pain compared to the traditional intercostal thoracoscopic approach.
14 September 2026 in Pirogov Russian Journal of Surgery
Objective. To identify clinical and morphological factors associated with favorable neurological outcomes after extended thymectomy in patients with generalized myasthenia gravis. Material and methods. A single-center retrospective study with prospective component included 103 patients with generalized myasthenia gravis who underwent extended thymectomy in 2009–2021. The primary endpoint was improvement in the Myasthenia Gravis Foundation of America (MGFA) Postintervention Status classification: sustained remission, pharmacological remission, or minimal manifestations. Potential predictors included thymus morphology, thymoma, period between manifestation and surgery, immunopathogenetic variant of myasthenia, preoperative QMG score, age, gender and characteristics of disease onset. Results. Improvement was achieved in 73 out of 103 patients (70.9%) after 3 years. Favorable outcome was more common in thymic hyperplasia compared to thymic involution (75.5% vs 66.0%), in patients without thymoma than in those with thymoma (73.3% vs 53.8%), as well as in case of surgery within 2 years after manifestation (76.7% vs 62.8%). Preoperative QMG cutoff of 26.5 identified patients with higher risk of no improvement (odds ratio 4.0; 95% CI 1.64–10.08; p = 0.02). Thymectomy efficacy was 74.5% in AChR-positive, 54.0% in MuSK-positive, and 33.0% in seronegative myasthenia gravis. Postoperative complications occurred in 4 patients (3.8%), conversion was required in 3 patients (2.9%), and no deaths or postoperative myasthenic crises were recorded. Conclusion. Preoperative stratification before thymectomy in generalized myasthenia gravis should integrate QMG score, disease time, thymoma status, and thymic morphology. QMG combined with clinical and morphological variables may be useful for predicting the expected benefit of surgery and for patient counseling.